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Abstract
The overall number of day-case otologic surgery cases is
increasing; however, there is limited experience about performing
canal wall down tympanoplasty in patients with chronic suppura-
tive otitis media with cholesteatoma in this setting. The objective
of this study was to assess the success of this technique as day-
case surgery in terms of results and complications over an 8-year
follow up period. We included in this study 42 patients undergoing
canal wall down technique tympanoplasty surgery for chronic
suppurative otitis media with cholesteatoma performed as day
cases during a 2-year period. 30 cases (71.4%) were discharged on
the day of surgery, whereas 12 cases (28.6%) were hospitalized
and discharged the day after. The principal reasons for failure of
discharge on the day of surgery were asthenia (6 cases), vertigo
and asthenia (4 cases), undetermined (2 cases). Based on our
experience, with a proper preoperative selection, assessment and
screening of the patients, mastoidectomy with timpanoplasty for
chronic suppurative otitis media with cholesteatoma can be car-
ried out in a day surgery setting without affecting results, compli-
cations and long-term relapse.
Introduction
Many procedures that in the past typically required overnight
hospital stay are now being performed in a day surgery setting.
Management of specific conditions using day-case surgery has
several advantages over inpatient surgery, such as reduced risk of
hospital infection, better quality of life, shorter waiting time, and
economic savings for the National Health Service. The American
Academy of Otolaryngology - Head and Neck Surgery has pub-
lished a suggested list of procedures deemed appropriate for out-
patient settings, including most otologic procedures such as
myringoplasty, tympanoplasty, simple mastoidectomy, stapes sur-
gery, middle ear exploration and reconstruction of the external
ear.1 The overall number of day-case otologic surgery cases is
increasing despite the complexity of same day hospital discharge,
especially for stapes surgery,2,3 myringoplasty,4,5 and tympa-
nomastoid surgery.6,7 There is less experience in day-case surgery
for chronic suppurative otitis media (CSOM) with cholesteatoma.8
The type of surgical procedure is one variable that can significant-
ly influence the nature of the postoperative course and the rate of
postoperative complications; complex procedures, such as tympa-
nomastoid surgery, may have a different postoperative course
compared to other surgical procedures.9
The three main reasons for failure of patient discharge on the
day of surgery after otologic surgery are vertigo, vomiting, and
asthenia.2 The incidence of postoperative nausea and vomiting
(PONV) in patients undergoing day surgery is approximately
35%;10 however, for patients undergoing otologic surgery it can be
as high as 80%.11 Various experiences highlight that prophylactic
administration of antiemetic drugs does not seem to influence the
incidence of vertigo and vomiting requiring hospital admission.
Other factors associated with the management of otologic surgery
in a day case setting are the length of general anesthesia (≥ 2 h),
the distance between home and hospital, age, poor health and asth-
ma or breathing difficulties as coexisting conditions.11,12
In this paper, we report our experience on canal wall down
(CWD) tympanoplasty in patients with CSOM with cholesteatoma
performed in the day surgery unit (DSU) of a large Italian hospital
with an 8-year follow up. This study included only cases of
cholesteatoma treated with a standardized canal wall down tym-
panoplasty technique and managed as day-case surgery cases. The
aim of this paper is to assess the success of this technique in a day
case setting in a large Italian hospital with a long-term follow-up.
Materials and Methods
Forty-two consecutive patients with CSOM with
cholesteatoma undergoing canal wall down tympanoplasty per-
formed as day-case surgery during a 2-year period (2008-2010)
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were included in the study. 
Before admission to the DSU of our hospital, all patients
underwent anamnestic interview, full ENT examination, pure tone
audiometry (PTA), computed tomography (CT) scan of mastoid
and middle ear without contrast. Diagnosis was based on otoscopy,
audiometric and CT scan findings.13 After admission, surgery was
performed the same morning by the same surgical team; it was
always possible to extend the period of hospitalization if required
by patient’s conditions. All the patients underwent a CWD mas-
toidectomy with tympanoplasty. The Italian Version of the Chronic
Ear Survey (CES-I) questionnaire14 was administered to all
patients before and 10 days after surgery. Informed consent was
obtained from all individual participants included in the study; all
procedures were in accordance with the ethical standards of the
Hospital Ethical Committee’s.
Patients underwent a standard anesthesia procedure with tra-
cheal intubation. A pre-anesthesia with atropine and clonidine, 1
hour before the induction, was used to reduce reflexes caused by
the stimulation of the external auditory canal. Once in the operat-
ing room the patients received 2 mg of midazolam and 1 mcg/kg
of fentanyl, associated to ondansetron and pantoprazole. Then
anesthesia was induced with propofol 1 mg/kg and rocuronium
0.3-0.4 mg/kg, and maintained with propofol 5 mg/kg/h + remifen-
tanyl 0.10-0.30 gamma/kg/min. Before the surgical incision
patients were treated with paracetamol and steroids to reduce
PONV and the release of pain factors. 9 patients underwent a bal-
anced anesthesia, while 33 patients were administered an intra-
venous anesthesia. In 12 patients, we managed general anesthesia
with intraoperative morphine. Intraoperative antiemetic drugs
were used in 12 patients to reduce the incidence of post-operatory
nausea and vomiting whereas their use was left to the discretion of
the otologist performing the surgery.
All procedures were performed using a postauricular approach.
Surgery followed the basic principle of CWD timpanoplasty that
consists in the eradication of the cholesteatoma and the exterioriza-
tion of the mastoid antrum in continuity with the external auditory
canal. In addition to removing all diseased air cells, a trouble-free
mastoid cavity was ensured by an adequate saucerization, an ade-
quate lowering of the facial ridge, the management of the mastoid
tip, and an adequate meatoplasty. In 18 patients, we used Silastic
sheeting in the ear cavity. At the end of the surgery all the patients
had a pressure dressing in the form of a head bandage. For same
day discharge, patients must feel generally well, have eaten and
drank without vomiting, and passed urine. Any pain must be within
acceptable limits and controllable with simple analgesia. 
Follow up visits were performed every year for an 8-year peri-
od (min: 7 years, max 9 years). 
Statistical analysis was performed on the results from the CES-
I questionnaire. Mean and standard deviation (SD) before and 10
days after surgery was calculated for each CES-I subscale. Before
and after surgery data was compared for statistical difference using
t-test; P-value less than 0.05 was considered the cut off for statis-
tical significance. The statistical analysis was conducted using
SPSS 22.0. 
Results
Forty-two consecutive patients, 24 males and 18 females, aged
between 17 and 67 years old (mean 44.8) were included in this
study. Patients reported episodes of recurrent otorrhea (30 cases),
worsening hearing loss (6 cases), or both (21 cases). The otoscopy
findings revealed a marginal perforation of the tympanic mem-
brane in all subjects.
The CT scan of ear and mastoid showed an involvement of the
tympanic cavity and ear bones with extension to the mastoid
antrum in all the cases. CSOM involved the right ear in 19 cases,
the left ear in the other 23 patients. Otoscopy examination and
radiological imaging were suggestive of CSOM with
cholesteatoma in all patients.
Preoperative audiometric evaluation of the ear involved by the
cholesteatoma showed a mean PTA of 50.6 dB HL with a mean gap
of 28.2 dB HL; postoperative audiometric evaluation, performed 2
months after surgery, showed a mean PTA of 46.8 dB HL with a
gap of 24.6 dB HL.
Before surgery, the average total score of CES-I questionnaire
was 58.44 (SD: 14.88); subscale scores were 57.56 (SD=25.73) for
the activity restriction-based subscale (AR), 57.58 (SD=15.6) for
the symptom subscale (ST), and 58.47 (SD=21.52) for the medical
resource utilization subscale (MR). There were improvements in
the total score and in each subscale score in postoperative CES
evaluation. The improvements in the AR and MR subscales and in
the total score were not significant but with P value slightly higher
than 0.05; the symptom subscale showed a significant improve-
ment after surgery with P=0.048 (P<0.05) (Table 1). Patient satis-
faction test (customer satisfaction) gave following day case major
ear surgery is good and comparable with that following in-patient
surgery.15
All the cases were first time surgery except two patients who
already underwent a canal wall up mastoidectomy with tym-
panoplasty respectively 4 and 7 years before and were then consid-
ered revision cases. 30 cases (71.4%) were discharged on the day
of surgery, whereas 12 cases (28.6%) were hospitalized and dis-
charged the day after. The principal reasons for failure of discharge
on the day of surgery were asthenia (6 cases), vertigo and asthenia
(4 cases), undetermined (2 cases). These reasons still represent
minor post-operative problems. Within hospitalized patients, 6
subjects received intraoperative morphine and antiemetic drugs.
There were no surgical complications such as bleedings or
hematoma as well as no cases of inner ear injuries, temporary or
permanent facial nerve paralysis, labyrinthitis, fistulae, gushers,
cerebrospinal fluid leaks. None of the patients who were dis-
charged the same day were readmitted to the hospital within 1
month after discharge. No sign of recurrence of cholesteatoma was
found in all patients after a follow-up period of 7 to 9 years.
                                Article
Table 1. CES-I results before and 10 days after surgery.
P-value                 After surgery                                               Before surgery                                                        CES-I subscale
0.057                                    70±23.1                                                                            57.5±25.7                                                                Activity restriction-based subscale
0.048                                  65.8±15.5                                                                           57.5±15.6                                                                               Symptom subscale
0.075                                  67.8±17.9                                                                           58.4±21.5                                                              Medical resource utilization subscale
0.067                                  64.8±17.9                                                                           58.4±14.8                                                                                      Total score
Discussion
Day-case surgery has gained widespread acceptance in the last
years thanks to new drugs to treat postoperative pain and nausea.
Financial factors have also contributed. Currently, the possibility
to perform ear surgery such as cochlear implants and stapes sur-
gery in a day-case surgery setting is elevate thanks to standardized
surgery techniques, experienced surgery team, and adequate anes-
thesia. Dickins et al. published a paper on the possibility to per-
form otological surgical procedures in an outpatient surgical set-
ting showing their results on 640 otologic surgical procedures
including tympanoplasty, stapedectomy, mastoidectomy and
labyrinthectomy. The Authors reported a percentage of discharging
on the same day, for the procedures performed in the outpatient
surgical setting, of 23% for tympanomastoidectomy and of 31%
for mastoidectomy, whereas most of the patients were hospitalized.
Most of the patients were revision cases.1
Postoperative nausea and vomiting is one of the most common
complications after day-case surgery, and it occurs following local,
regional, and general anesthesia. Factors affecting PONV include
age, sex, type of surgery, anxiety, history of motion sickness, post-
operative pain, and use of opioids. The incidence of PONV is par-
ticularly common in patients undergoing otologic surgical proce-
dures, for which it has been described an incidence as high as
80%.16,17 Megerian et al. reported that a history of motion sickness
can be predictive of PONV and increased hospital length of stay in
adults undergoing tympanomastoidectomy.9
In our patient series, there were no cases of iatrogenic inner ear
injury leading to complications such as sensorineural hearing loss
or vertigo. Preoperative bone lines were preserved in all patients.
Therefore, PONV was most likely due to other factors such as pre-
operative medications and the stress induced on the ear by a com-
bination of prolonged exposure, caloric and suction-irrigation, and
high-speed drilling of the bones surrounding the labyrinth.
Physical stimulation following drilling and irrigation adjacent
to the inner ear has been correlated to the development of PONV
after tympanomastoid surgery. It has been shown that stimulation
of inner ear structures by low-frequency sounds causes postural
instability in patients undergoing middle ear surgery for chronic
otitis media. Suction and irrigation during surgery also stimulate
the vestibular apparatus, which can further increase the incidence
of PONV. Thus, it has been postulated that one of the major causes
of PONV after tympanomastoid surgery may be represented by
physical stimulation.18-20
Megerian et al. demonstrated that prophylactic administration
of antiemetic drugs did not positively influence PONV incidence.
The Authors did not use dolasetron or other 5-HT3 receptor antag-
onists; however, they did use other antiemetics, primarily droperi-
dol, in 45% of their patients. Megerian also reported that up to 33%
of patients undergoing tympanomastoidectomy were discharged
from the Post-Anesthesia Care Unit (PACU). The mean age of
patients in that study was 34.5 years (range: 2-73 years).9
The results of literature for mastoid surgery are less promising
compared to other ear procedures. Dornhoffer published the results
of the University of Arkansas, USA for patients up to the age of 18
undergoing tympanomastoidectomy; the Authors reported that
14/75 (18.6%) patients required overnight hospital stay.21 A study
of Rowlands et al. on ear surgery in a pediatric DSU showed that
100% of the children (7 cases) who underwent surgery for
cholesteatoma were dismissed on the same day of surgery, whereas
1 patient was admitted to DSU the following day requiring
antiemetic drugs and i.v. hydration.22 Because of the retrospective
nature of the study, other important factors, such as concurrent
medical conditions and poor family support were not assessed.
Patients with low or no comorbidity and excellent family support
are more likely to leave the hospital earlier.
According to Dickins et al. more than 60% of the patients who
undergo otologic procedures can be managed in a day-case surgery
basis, including tympanomastoidectomy.23 In a UK study from
2002, 40.6% of pediatric patients were discharged on the day of
surgery. The same study showed that minor mastoid procedures
such as atticotomy could be performed as day cases. The number
of more complex mastoid operations (including modified radical
mastoidectomy) performed in a day-case surgery setting in that
study was 75%, however the number of patients enrolled (12 chil-
dren) were too small to convincingly show that they could be safe-
ly and routinely performed in this way.24
Powell et al. performed 52 middle ear operations, including 10
mastoidectomies, in a day-case setting on a pediatric population,
with a 40% incidence of PONV and 30% of postoperative pain,
reaching great results with a good follow-up. In this study the most
common anaesthetic induction agents used were fentanyl (1
mg/kg) and propofol (2 mg/kg) with maintenance of anaesthesia
using a combination of sevoflurane, oxygen and nitrous oxide. All
patients received intra-operative anti-emetic prophylaxis with
ondansetron and/or cyclizine and/or dexamethasone.25
In another study on a pediatric population, Hasan et al. includ-
ed 89 cases of cholesteatoma on 152 tympanomastoid surgical pro-
cedures for 144 children.6 In 4 cases, they observed the facial
nerve involvement by cholesteatoma. Patients who underwent
mastoid procedures had a greater length of anesthesia and surgery,
were more likely to receive intraoperative cefazoline sodium and
IV morphine sulfate in the PACU, and were less likely to be dis-
charged from PACU compared with patients who underwent mid-
dle ear procedures. Dolasetron Mesylate was used as a prophylac-
tic antiemetic toward the end of surgery in 113 cases (74%) and did
not have a statistically significant effect on the occurrence of
PONV (P=0.60). A higher percentage of patients who underwent
mastoid procedures received Dolasetron Mesylate as a prophylac-
tic antiemetic during surgery compared with patients who under-
went middle ear procedures; however, there was no statistically
significant difference (P=0.30) between the 2 groups regarding the
occurrence of PONV that required postoperative antiemetic drugs.
Patients who underwent mastoid procedures required a higher
number of doses of antiemetics to control PONV in the PACU. In
this group, the presence of cholesteatoma and the need for i.v. mor-
phine sulfate for pain at the time of admission to Day Surgery Unit
were associated with a higher risk of PONV. Also, in this group the
presence of a pain score of 5 or greater at the time of admission to
DSU, which was treated with i.v. morphine sulfate, was associated
with failure to discharge from the hospital on the day of surgery.
The occurrence of PONV and the hospital length of stay was not
different between canal wall up and canal wall down procedures.
On 84 mastoid procedures (tympanoplasty with atticotomy/antros-
tomy or mastoidectomy), only 15 cases were discharged home
from the DSU. The principal reasons for failure of discharge on the
day of surgery were PONV and postoperative pain.
All patients underwent a long-term follow-up period of 7 to 9
years. No sign of recurrence of cholesteatoma was found in all
patients during follow up, demonstrating long-term effectiveness
of day-case management of CSOM with cholesteatoma also in
term of recurrences, that did not significantly differ from overnight
hospital stay management of this condition. 
Conclusions
Our experience demonstrates that with a proper preoperative
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selection, assessment and screening of the patients and a well-
staffed and equipped surgical facility, most adults can be dis-
charged home from the hospital within 23 h after mastoidectomy
with tympanoplasty for CSOM with cholesteatoma surgery with
no significant effects on effectiveness of surgery, post-operative
symptoms and relapse of disease even in the long term. Adults who
undergo more complex middle ear surgical procedures are more
likely to require an overnight observation. Postoperative pain
requiring i.v. opioids and PONV are the two principal reasons for
failure to discharge from the hospital on the day of the surgery.
Adults with an underlying CSOM with cholesteatoma are at a
higher risk of PONV. 
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